Regeneron Cites Medtronic Ruling In Amgen Bundling Case

By Cara Salvatore · July 9, 2026, 9:32 PM EDT

Regeneron has told a Delaware federal judge there is new reason to preserve its $407 million win against Amgen over cholesterol drug bundling after a California federal judge found in an...

To view the full article, register now.

Documents

Case Information

Case Title

Regeneron Pharmaceuticals, Inc. v. Amgen Inc.

Case Number

1:22-cv-00697

Court

Delaware

Nature of Suit

Anti-Trust

Date Filed

May 27, 2022